Trial intelligence / Profile preview

Effect of oral zolpidem on hemodynamic indices and patient equilibrium in stereotaxic surgeries

IRCT20110528006617N6Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of zolpidem in Cardiovascular collapse and Postoperative balance impairment (PBI), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Change in hemodynamic indices and Patient equilibrium. Started Jul 2021; status: completed.

02

Drugs

zolpidem
03

Conditions

Cardiovascular collapsePostoperative balance impairment (PBI)

Beyond the preview

Go deeper on IRCT20110528006617N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20110528006617N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call